Teza Capital Management LLC Dynavax Technologies Corp Transaction History

Teza Capital Management LLC

  • $809 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 22, 2024
SELL
$12.64 - $14.99 $184,746 - $219,093
-14,616 Reduced 25.77%
42,112 $621,000
Q3 2023

Nov 14, 2023
SELL
$12.64 - $14.99 $344,098 - $408,072
-27,223 Reduced 26.36%
76,057 $1.12 Million
Q2 2023

Feb 22, 2024
BUY
$9.85 - $13.17 $558,770 - $747,107
56,728 New
56,728 $732,000
Q2 2023

Aug 14, 2023
BUY
$9.85 - $13.17 $837,939 - $1.12 Million
85,070 Added 467.16%
103,280 $1.33 Million
Q1 2023

May 15, 2023
BUY
$9.44 - $11.88 $171,902 - $216,334
18,210 New
18,210 $178,000

Others Institutions Holding DVAX

# of Institutions
257
Shares Held
132M
Call Options Held
371K
Put Options Held
99.2K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.44B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email